NPI: 1336174325 · COACHELLA, CA 92236 · Community Health Clinic/Center · NPI assigned 07/11/2006
Authorized official GONZALES, THERESA controls 19+ related entities in our dataset. Read more
| Authorized Official | GONZALES, THERESA (DIRECTOR OF BILLING) |
| NPI Enumeration Date | 07/11/2006 |
Other providers sharing the same authorized official: GONZALES, THERESA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,994 | $1.21M |
| 2019 | 79,658 | $5.33M |
| 2020 | 77,110 | $5.51M |
| 2021 | 82,475 | $4.39M |
| 2022 | 105,755 | $5.36M |
| 2023 | 116,133 | $5.87M |
| 2024 | 117,854 | $5.77M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 6,757 | 6,743 | $3.58M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 3,420 | 3,403 | $3.26M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46,977 | 45,657 | $2.94M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 54,911 | 54,093 | $2.58M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 54,901 | 54,093 | $2.57M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25,020 | 24,346 | $2.46M |
| S4993 | Contraceptive pills for birth control | 15,076 | 14,929 | $1.76M |
| J3490 | Unclassified drugs | 37,628 | 35,526 | $1.60M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9,733 | 9,656 | $1.53M |
| 87806 | 50,442 | 48,084 | $1.30M | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 28,373 | 27,664 | $1.29M |
| 59840 | 3,056 | 3,048 | $943K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 27,792 | 27,601 | $871K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 9,940 | 9,809 | $858K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 683 | 683 | $653K |
| S0190 | Mifepristone, oral, 200 mg | 9,387 | 9,351 | $582K |
| J7304 | Contraceptive supply, hormone containing patch, each | 712 | 705 | $554K |
| J7300 | Intrauterine copper contraceptive (paragard) | 566 | 562 | $480K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 10,228 | 9,906 | $438K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 450 | 447 | $428K |
| 11981 | 1,666 | 1,658 | $336K | |
| A4267 | Contraceptive supply, condom, male, each | 24,104 | 22,780 | $292K |
| 58300 | 1,630 | 1,577 | $235K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2,478 | 2,458 | $205K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5,586 | 5,483 | $183K |
| J7301 | Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg | 209 | 206 | $166K |
| 81025 | 52,533 | 51,461 | $149K | |
| 99000 | 40,011 | 38,816 | $147K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | 147 | 147 | $137K |
| 99152 | 2,856 | 2,841 | $134K | |
| 11982 | 929 | 922 | $102K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 454 | 451 | $83K |
| 99201 | 1,802 | 1,775 | $80K | |
| 87529 | 999 | 998 | $59K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,041 | 3,030 | $57K |
| 83986 | 17,794 | 17,217 | $56K | |
| 59841 | 111 | 109 | $53K | |
| Q3014 | Telehealth originating site facility fee | 2,227 | 2,189 | $52K |
| 58301 | 933 | 901 | $40K | |
| 87210 | 10,859 | 10,664 | $38K | |
| S0191 | Misoprostol, oral, 200 mcg | 8,451 | 8,256 | $26K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 127 | 127 | $13K |
| 85018 | 10,778 | 10,465 | $12K | |
| 90651 | 41 | 39 | $11K | |
| 57454 | 155 | 103 | $10K | |
| 86701 | 1,403 | 1,334 | $10K | |
| S5000 | Prescription drug, generic | 1,876 | 1,796 | $10K |
| 90385 | 200 | 200 | $10K | |
| S5199 | Personal care item, nos, each | 2,120 | 2,108 | $10K |
| 81002 | 3,953 | 3,885 | $9K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 573 | 573 | $7K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 116 | 114 | $7K |
| 11976 | 57 | 52 | $6K | |
| 86901 | 2,027 | 2,017 | $2K | |
| 76998 | 26 | 26 | $2K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 276 | 225 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 655 | 644 | $729.37 |
| A4268 | Contraceptive supply, condom, female, each | 16 | 16 | $39.52 |
| 36415 | Collection of venous blood by venipuncture | 708 | 670 | $0.00 |